Servicio de Cardiología.
Servicio de Medicina Intensiva.
Eur J Heart Fail. 2018 Feb;20(2):385-394. doi: 10.1002/ejhf.886. Epub 2017 Jun 5.
To analyse the incidence, risk factors and clinical outcomes of late graft failure after heart transplantation.
We conducted an observational, single-centre study based on 547 patients who underwent cardiac transplantation from 1991 to 2014 and who survived the in-hospital postoperative period. Late graft failure was defined as the first hospitalization due to this condition after discharge. Over a mean follow-up of 8.4 ± 6 years, 178 (32.5%) patients were hospitalized due to late graft failure [incidence rate: 3.6 cases per 100 patient-years, 95% confidence interval (CI) 3.1-4.2]. Pre-transplant diabetes, higher pre-transplant transpulmonary pressure gradient and lower donor-recipient weight ratio were independently associated with higher risk of graft failure. Cardiac allograft vasculopathy, cellular rejection grade ≥1R, and antibody-mediated rejection grade ≥1 were detected in 50.6%, 44.9% and 19.2% patients, respectively, admitted due to graft failure. Left ventricular ejection fraction was ≥50% in 60.1% of these patients. Re-transplant free survival 1, 5, 10 and 15 years after the diagnosis of late graft failure was 72.2%, 38.4%, 18.4%, and 7.5%, respectively; the incidence rate of re-hospitalization due to decompensated heart failure was 40.9 episodes per 100 patient-years (95% CI 36.6-46.1). The need for inotropes, the presence of cardiac allograft vasculopathy, higher creatinine serum levels, lower ejection fraction and lower sodium serum levels were independent predictors of worse outcomes.
Late graft failure is frequent after heart transplantation, as it is associated with poor outcomes. Rejection and cardiac allograft vasculopathy are the most frequent underlying causes.
分析心脏移植后晚期移植物失功的发生率、危险因素和临床转归。
我们进行了一项观察性、单中心研究,纳入了 1991 年至 2014 年期间接受心脏移植且术后住院期间存活的 547 例患者。晚期移植物失功定义为出院后首次因该情况住院。在平均 8.4±6 年的随访中,178 例(32.5%)患者因晚期移植物失功住院[发生率:每 100 患者年 3.6 例,95%置信区间(CI)3.1-4.2]。移植前糖尿病、较高的跨肺压梯度和较低的供受者体重比与移植物失功风险增加独立相关。因移植物失功住院的患者中,分别有 50.6%、44.9%和 19.2%检测到心脏移植物血管病、细胞性排斥反应≥1R 级和抗体介导的排斥反应≥1R 级。这些患者中,左心室射血分数≥50%的比例为 60.1%。晚期移植物失功诊断后 1、5、10 和 15 年的再次移植无失功生存率分别为 72.2%、38.4%、18.4%和 7.5%;因心力衰竭失代偿而再住院的发生率为每 100 患者年 40.9 例(95%CI 36.6-46.1)。需要使用正性肌力药、存在心脏移植物血管病、较高的血肌酐水平、较低的射血分数和较低的血钠水平是预后不良的独立预测因素。
心脏移植后晚期移植物失功较为常见,与不良结局相关。排斥反应和心脏移植物血管病是最常见的潜在原因。